DXS INTERNATIONAL PLC
Clarification of Significant Shareholding
The Board of DXS International plc (the “Company”), the NEX quoted clinical decision support developer and supplier of clinical decision support systems has just concluded a review of its share register and has discovered that the holdings of Mr David Immelman and persons closely associated to him have been slightly under-reported by 41,793 Ordinary shares and wish to correct the position.
For the record Mr Immelman, and persons closely associated with him, currently hold 3,743,466 Ordinary Shares in the Company constituting 10.52% of the current issued share capital of 35,581,416 rather than 10.40% as reported in the Company’s announcement of 9th April 2019.
The Directors of DXS International plc accept responsibility for this announcement.
Enquiries:
| David Immelman (Chief Executive) DXS International plc | 01252 719800 david@dxs-systems.com |
| Wrecclesham House Wrecclesham Road Farnham Surrey GU10 4PS | |
| www.dxs-systems.co.uk |
| David Papworth City & Merchant | 0207 101 7676 info@cityandmerchant.com |
| Level 17, Dashwood House 69 Old Broad Street, London EC2M 1QS |
Note to Editors:
DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively which should significantly contribute towards the NHS achieving its projected efficiency savings.